Patient Activation of Persons With Opioid Use Disorder in Intensive Outpatient Treatment

Abstract

Background

High patient activation is associated with a variety of positive health outcomes. Although increasing patient activation in persons with opioid use disorder (OUD) in intensive outpatient treatment (IOT) programs may increase engagement and improve outcomes, little is known about how patient activation is manifested in these programs.

Aims

To describe types of instances in which persons play an active role in their IOT or show self-determination in their recovery generally (patient activation) and types of instances in which they play a passive role in their IOT or have recovery directed by others (patient nonactivation).

Methods

A qualitative descriptive study using data from a larger grounded theory study was conducted. Interviews were completed with 14 persons with OUD who attended an IOT program within a large health care system in the Midwest. Content analysis was used to create a typology of instances of patient activation or nonactivation in participants’ IOT experiences.

Results

Six types of instances were identified: (1) making and enacting one’s own treatment decisions, (2) actively collaborating with staff, (3) self-determining one’s disclosure in groups, (4) making a commitment to treatment, (5) taking responsibility for one’s recovery, and (6) taking actions to avoid return to use.

Conclusions

Patient activation is multidimensional and plays a salient role in IOT experiences. IOT staff should engage patients as active participants in their treatment and encourage mutual goal-setting and shared-decision but should be aware that some approaches used too early in treatment may impede recovery.

Keywords

patient activation intensive outpatient treatment opioid use disorder

Get full access to this article

View all access options for this article.

References

Allen

M. L.

Cook

B. L.

Carson

Interian

La Roche

Alegría

(2017). Patient-provider therapeutic alliance contributes to patient activation in community mental health clinics. Administration and Policy in Mental Health and Mental Health Services Research, 44(4), 431–440. https://doi.org/10.1007/s10488-015-0655-8

American Addiction Centers. (2020). Alcohol and drug abuse statistics. https://americanaddictioncenters.org/rehab-guide/addiction-statistics

American Addiction Centers. (2021). 12 step programs: 12 steps to recovery for drug & alcohol treatment. https://americanaddictioncenters.org/rehab-guide/12-step

American Psychiatric Association. (2018). Opioid use disorder. https://www.psychiatry.org/patients-families/addiction/opioid-use-disorder/opioid-use-disorder

Centers for Disease Control and Prevention. (n.d.). Module 5: Assessing and addressing opioid use disorder (OUD). https://www.cdc.gov/drugoverdose/training/oud/accessible/index.html

Chiang

Chang

Nakash

Cruz-Gonzalez

Fillbrunn

M. K.

Alegria

. (2019). Change in patient activation and mental illness symptoms after communication training: A multisite study with a diverse patient sample. Psychiatric Services, 70(8), 696–702. https://doi.org/10.1176/appi/ps/201800216

Dalton

Bishop

Darcy

(2021). Addictive behaviors investigating interventions that lead to the highest treatment retention for emerging adults with substance use disorder: A systematic review. Addictive Behaviors, 122, 107005. https://doi.org/10.1016/j.addbeh.2021.107005

Dillon

P. J.

Kedia

S. K.

Isehunwa

O. O.

Sharma

(2020). Motivations for treatment engagement in a residential substance use disorder treatment program: A qualitative study. Substance Abuse: Research and Treatment, 14, 1178221820940682. https://doi.org/10.1177/1178221820940682

Eliacin

Salyers

M. P.

Kukla

Matthias

M. S.

(2015). Factors influencing patients’ preferences and perceived involvement in shared decision-making in mental health care. Journal of Mental Health, 24(1), 24–28. https://doi.org/10.3109/09638237.2014.954695

10.

Florence

C. S.

Zhou

Luo

(2016). The economic burden of prescription opioid overdose. Medical Care, 54(10), 901–906.

11.

Gibert

S. H.

DeGrazia

Danis

(2017). Ethics of patient activation: Exploring its relation to personal responsibility, autonomy and health disparities. Journal of Medical Ethics, 43(10), 670–675. https://doi.org/10.1136/medethics-2017-104260

12.

Greene

Hibbard

J. H.

(2012). Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. Journal of General Internal Medicine, 27(5), 520–526. https://doi.org/10.1007/s11606-011-1931-2

13.

Hawk

Coulter

R. W. S.

Egan

J. E.

Fisk

Friedman

M. R.

Tula

Kinsky

(2017). Harm reduction principles for healthcare settings. Harm Reduction Journal, 14(70), 1–9. https://doi.org/10.1186/s12954-017-0196-4

14.

Hibbard

J. H.

Greene

(2013). What the evidence shows about patient activation: Better health outcomes and care experiences; fewer data on costs. Health Affairs, 32(2), 207–214. https://doi.org/10.1377/hlthaff.2012.1061

15.

Hibbard

J. H.

Greene

Shi

Mittler

Scanlon

(2015). Taking the long view: How well do patient activation scores predict outcomes four years later? Medical Care Research and Review, 72(3), 324–337. https://doi.org/10.1177/1077558715573871

16.

Hibbard

J. H.

Stockard

Mahoney

E. R.

Tusler

(2004). Development of the Patient Activation Measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Services Research, 39(4), 1005–1026. https://doi.org/10.1111/j.1475-6773.2004.00269.x

17.

Janssen

R. M. J.

Satink

Ijspeert

van Alfen

Groothuis

J. T.

Packer

T. L.

Cup

E. H. C.

(2019). Reflections of patients and therapists on a multidisciplinary rehabilitation programme for persons with brachial plexus injuries. Disability and Rehabilitation, 41(12), 1427–1434. https://doi.org/10.1080/09638288.2018.1430175

18.

Keen

Draucker

C. B.

(2022). Connecting and disconnecting: Experiences of persons with opioid use disorder in intensive outpatient treatment. Journal of Substance Abuse Treatment, 135, 108657.

19.

Kinney

R. L.

Lemon

S. C.

Person

S. D.

Pagoto

S. L.

Saczynski

J. S.

(2015). The association between patient activation and medication adherence, hospitalization, and emergency room utilization in patients with chronic illnesses: A systematic review. Patient Education and Counseling, 98(5), 545–552. https://doi.org/10.1016/j.pec.2015.02.005

20.

Loveland

Driscoll

(2014). Examining attrition rates at one specialty addiction treatment provider in the United States: A case study using a retrospective chart review. Substance Abuse Treatment, Prevention, and Policy, 9(41), 1–14. https://doi.org/10.1186/1747-597X-9-41

21.

McCance-Katz

(2018). SAMHSA/HHS: An update on the opioid crisis.

22.

McCarty

Braude

Lyman

D. R.

Dougherty

R. H.

Daniels

A. S.

Ghose

S. S.

Delphin-Rittmon

M. E.

(2014). Substance abuse intensive outpatient programs: Assessing the evidence. Psychiatric Services, 65(6), 718–726. https://doi.org/10.1176/appi.ps.201300249

23.

Mccusker

Lambert

S. D.

Cole

M. G.

Ciampi

Strumpf

Freeman

E. E.

Belzile

(2016). Activation and self-efficacy in a randomized trial of a depression self-care intervention. Health Education & Behavior, 43(6), 716–725. https://doi.org/10.1177/1090198116637601

24.

McDonall

De Steiger

Reynolds

Redley

Livingston

P. M.

Hutchinson

A. F.

Botti

(2019). Patient activation intervention to facilitate participation in recovery after total knee replacement (MIME): A cluster randomised cross-over trial. BMJ Quality and Safety, 28(10), 782–792. https://doi.org/10.1136/bmjqs-2018-008975

25.

Miles

M. B.

Huberman

Saldana

(2018). Qualitative data analysis: A methods sourcebook (4th ed.). SAGE.

26.

Muralidharan

Brown

C. H.

Peer

J. E.

Klingaman

E. A.

Hack

S. M.

Goldberg

R. W.

(2019). Living well: An intervention to improve medical illness self-management among individuals with serious mental illness. Psychiatric Services, 70(1), 19–25. https://doi.org/10.1176/appi.ps.201800162

27.

National Institute on Drug Abuse. (2017). Recovery. https://www.drugabuse.gov/related-topics/recovery

28.

Neale

Nettleton

Pickering

(2013). Does recovery-oriented treatment prompt heroin users prematurely into detoxification and abstinence programmes? Qualitative study. Drug and Alcohol Dependence, 127, 163–169. https://doi.org/10.1016/j.drugalcdep.2012.06.030

29.

Pinto

M. D.

Greenblatt

A. M.

Williams

B. L.

Kaplin

A. I.

(2017). Exploring the mechanism of the clinical encounter on depressive symptoms in young adults: A path analysis. Issues in Mental Health Nursing, 38(7), 533–539. https://doi.org/10.1080/01612840.2017.1305023

30.

Sacks

R. M.

Greene

Hibbard

J. H.

Overton

(2014). How well do patient activation scores predict depression outcomes one year later? Journal of Affective Disorders, 169, 1–6. https://doi.org/10.1016/j.jad.2014.07.030

31.

Saha

Kerridge

Goldstein

Chou

Zhang

Jung

Grant

(2016). Nonmedical prescription opioid use and DSM-5 nonmedical prescription opoioid use disorder in the United States. Journal of Clinical Psychology, 76(6), 772–780. https://doi.org/10.4088/JCP.15m10386

32.

Salyers

M. P.

Matthias

M. S.

Spann

C. L.

Lydick

J. M.

Rollins

A. L.

Frankel

R. M.

(2009). The role of patient activation in psychiatric visits. Psychiatric Services, 60(11), 1535–1539. https://doi.org/10.1176/ps.2009.60.11.1535

33.

Sandelowski

(2000). Focus on research methods: Whatever happened to qualitative description? Research in Nursing and Health, 23(4), 334–340. https://doi.org/10.1002/1098-240x(200008)23:4<334::aid-nur9>3.0.co;2-g

34.

Scholl

Seth

Kariisa

Wilson

Baldwin

(2019). Drug and opioid-involved overdose deaths—United States, 2013–2017. Morbidity and Mortality Weekly Report. https://www.cdc.gov/mmwr/volumes/67/wr/mm675152e1.htm

35.

Singla

D. R.

Hollon

S. D.

Velleman

Weobong

Nadkarni

Fairburn

C. G.

Patel

(2020). Temporal pathways of change in two randomized controlled trials for depression and harmful drinking in Goa, India. Psychological Medicine, 50(1), 68–76. https://doi.org/10.1017/S0033291718003963

36.

Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health indicators in the United States: Results from the 2018 national survey on drug use and health (HHS Publication No. PEP19-5068, NSDUH Series H-54). https://doi.org/10.1016/j.drugalcdep.2016.10.042

37.

Substance Abuse and Mental Health Services Administration (US). (2006). Intensive outpatient treatment and the continuum of care. In substance abuse: Clinical issues in intensive outpatient treatment (treatment). Substance Abuse and Mental Health Services Administration (US). https://www.ncbi.nlm.nih.gov/books/NBK64088/

38.

Tatarsky

Marlatt

G. A.

(2010). State of the art in harm reduction psychotherapy: An emerging treatment for substance misuse. Journal of Clinical Psychology, 66(2), 117–122. https://doi.org/10.1002/jclp.20672

39.

Tong

Sainsbury

Craig

(2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349–357. https://doi.org/10.1093/intqhc/mzm042

40.

Turner

Realpe

A. X.

Wallace

L. M.

Kosmala-anderson

(2015). A co-produced self-management programme improves psychosocial outcomes for people living with depression. Mental Health Review Journal, 20(4), 242–255. https://doi.org/10.1108/MHRJ-05-2014-0017

41.

Weisner

C. M.

Chi

F. W.

Ross

T. B.

Wood

S. B.

Hinman

Sterling

S. A.

(2016). Examination of the effects of an intervention aiming to link patients receiving addiction treatment with health care the LINKAGE clinical trial. JAMA Psychiatry, 73(8), 804–814. https://doi.org/10.1001/jamapsychiatry.2016.0970